Literature DB >> 16193290

Glucose-induced Akt1 activation mediates fibronectin synthesis in endothelial cells.

X Xin1, Z A Khan, S Chen, S Chakrabarti.   

Abstract

AIMS/HYPOTHESIS: Increased expression and decreased degradation of extracellular matrix (ECM) proteins are key features of chronic diabetic complications. Fibronectin, a predominant ECM protein, has been shown to be overexpressed in all target organs of diabetic complications and in endothelial cells cultured in high levels of glucose. The present study was designed to elucidate the role of protein kinase B (Akt/PKB) in glucose-induced fibronectin mRNA expression and protein production in vascular endothelial cells.
METHODS: Human umbilical vein endothelial cells were cultured in the presence of high glucose to study Akt/PKB activation. The upstream and downstream mediators in the Akt/PKB pathway were also investigated using dominant negative transfections and specific inhibitors of signalling pathways. Cells were subjected to real time RT-PCR, western blotting, and confocal microscopy to assess Akt1/PKBalpha activation and fibronectin mRNA expression and protein production. To detect transcription factor activation, electrophoretic mobility shift assay was carried out.
RESULTS: Our data demonstrate that fibronectin mRNA expression and protein production that are induced by high glucose are mediated via activation of Akt/PKB, which is modulated by mitogen-activated protein kinase, phosphatidylinositol 3-kinase, and protein kinase C. Glucose-induced fibronectin mRNA expression and protein production are also mediated by Akt1/PKBalpha-dependent activation of the transcription factors nuclear factor-kappaB and activating protein-1. CONCLUSIONS/
INTERPRETATION: Our study provides insight into the mechanical basis of glucose-induced increases in fibronectin mRNA expression and protein production. High levels of glucose may increase fibronectin mRNA expression and protein production by activating Akt/PKB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16193290     DOI: 10.1007/s00125-005-1939-4

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  39 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 2.  New insights into the role of nuclear factor-kappaB in cell growth regulation.

Authors:  F Chen; V Castranova; X Shi
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 3.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

4.  Proliferative effect of high glucose is modulated by antisense oligonucleotides against fibronectin in rat endothelial cells.

Authors:  S Roy; T Roth
Journal:  Diabetologia       Date:  1997-09       Impact factor: 10.122

5.  Induction of NF-kappaB by the Akt/PKB kinase.

Authors:  L P Kane; V S Shapiro; D Stokoe; A Weiss
Journal:  Curr Biol       Date:  1999-06-03       Impact factor: 10.834

Review 6.  Cell surface interactions with extracellular materials.

Authors:  K M Yamada
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

7.  High glucose-induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1.

Authors:  Shali Chen; Suranjana Mukherjee; Chandan Chakraborty; Subrata Chakrabarti
Journal:  Am J Physiol Cell Physiol       Date:  2002-09-18       Impact factor: 4.249

8.  Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP.

Authors:  E Cagliero; T Roth; S Roy; M Maiello; M Lorenzi
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.

Authors:  K I Ishibashi ; T Imamura; P M Sharma; J Huang; S Ugi; J M Olefsky
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

10.  Akt is a downstream target of NF-kappa B.

Authors:  Fanyin Meng; Li Liu; Paul C Chin; Santosh R D'Mello
Journal:  J Biol Chem       Date:  2002-06-06       Impact factor: 5.157

View more
  6 in total

1.  Translationally controlled tumour protein is associated with podocyte hypertrophy in a mouse model of type 1 diabetes.

Authors:  D K Kim; B Y Nam; J J Li; J T Park; S H Lee; D H Kim; J Y Kim; H Y Kang; S H Han; T H Yoo; D S Han; S W Kang
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

2.  PKC-beta1 mediates glucose-induced Akt activation and TGF-beta1 upregulation in mesangial cells.

Authors:  Dongcheng Wu; Fangfang Peng; Baifang Zhang; Alistair J Ingram; Darren J Kelly; Richard E Gilbert; Bo Gao; Joan C Krepinsky
Journal:  J Am Soc Nephrol       Date:  2009-02-11       Impact factor: 10.121

3.  High glucose increases lysyl oxidase expression and activity in retinal endothelial cells: mechanism for compromised extracellular matrix barrier function.

Authors:  Argyrios Chronopoulos; Amanda Tang; Ekaterina Beglova; Philip C Trackman; Sayon Roy
Journal:  Diabetes       Date:  2010-09-07       Impact factor: 9.461

4.  High glucose promotes retinal endothelial cell migration through activation of Src, PI3K/Akt1/eNOS, and ERKs.

Authors:  Qiong Huang; Nader Sheibani
Journal:  Am J Physiol Cell Physiol       Date:  2008-10-22       Impact factor: 4.249

Review 5.  Cellular signaling and potential new treatment targets in diabetic retinopathy.

Authors:  Zia A Khan; Subrata Chakrabarti
Journal:  Exp Diabetes Res       Date:  2007

Review 6.  Noncoding RNAs as therapeutic targets in early stage diabetic kidney disease.

Authors:  Mitsuo Kato
Journal:  Kidney Res Clin Pract       Date:  2018-09-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.